Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:


Micro-gyroscopes that can detect cancer


A vibrating disc no bigger than a speck of dust could help to diagnose and monitor common types of cancer and provide specialists with information about the most appropriate therapy.

The European Commission has this month awarded 12 million Euros to an international consortium led by Newcastle University, England, to develop the biosensor technology towards clinical trials stage.

The research team aims to produce a hand-held device which would enable samples of blood, smear or biopsy to be tested quickly and accurately, for signs of cancer of the breast, cervix, colon or rectum.

The device would identify ’cancer specific markers’ - proteins or other molecules produced by cancer cells - which vary according to the type of cancer and are distinct from proteins produced by healthy cells.

The researchers have manufactured discs less than one-tenth of a millimetre in diameter and coated them with special patterns of DNA or proteins which cause the cancer-specific markers to bind to the surface.

The discs are created in a silicon wafer and made to vibrate electronically in two modes. When a cancer-specific marker binds to the surface of a disc, in the pattern of the coating, the uneven weight causes one of the modes of vibration to change in frequency.

The difference between the frequencies of the two modes of vibration is measured, enabling the detection of tiny amounts of cancer specific marker. In theory, even the weight of a single molecule binding to the surface of a disc could be detected. .

Professor Calum McNeil, of the School of Clinical and Laboratory Sciences at Newcastle University, who is leading the project, said: ’We are confident that this new technology has the potential to improve the prospects of successful treatment for these cancers’.

’Early diagnosis and effective monitoring of cancers are known to be key factors influencing outcome. In addition, the technology could provide specialists with advice about the most appropriate therapy for a particular patient, since the devices could easily be connected to sources of information such as a hospital computer network, the internet or a mobile phone.’

Initial research was funded by the LINK Analytical Biotechnology Initiative, sponsored by the Biotechnology and Biological Sciences Research Council (BBSRC) and the Department of Trade and Industry.

The technology could eventually be developed for other types of cancer and a range of other diseases, including those caused by bacteria. This opens up the possibility of hospitals being able to screen new patients and visitors for MRSA, tuberculosis and other diseases to prevent the infections being carried into the wards.

Potential uses do not stop at medicine. In theory, the technology could be used to detect particles from biological or chemical weapons, providing an early warning system against terrorist attacks.

Professor McNeil collaborated closely with colleagues in engineering and life sciences at Newcastle University*. In fact, the idea of vibrating discs was inspired by earlier work at the University involving the manufacture of micro-gyroscopes, which are now standard equipment in many devices that detect movement, from navigation equipment to car air-bags.

At the heart of a micro-gyroscope is a vibrating disc that must be almost perfectly formed to operate correctly. Professor McNeil realised that a near-perfect disc could be turned into an extremely sensitive weighing machine because the addition of a tiny weight would make it vibrate unevenly.

European Commission funding for the project, known as Smart Integrated Biodiagnostic Systems for Healthcare, or SmartHEALTH for short, officially begins in December 2005, via the European Commission’s Framework 6 programme.

The research consortium comprises four universities, seven research institutes, 11 SMEs (small to medium-sized enterprises), three large companies and four clinical centres in the UK, Germany, Netherlands, Spain, Belgium, Ireland, Switzerland, Italy, Norway, Sweden and Australia.

Professor Calum McNeil | alfa
Further information:

More articles from Health and Medicine:

nachricht NIH scientists describe potential antibody treatment for multidrug-resistant K. pneumoniae
14.03.2018 | NIH/National Institute of Allergy and Infectious Diseases

nachricht Researchers identify key step in viral replication
13.03.2018 | University of Pittsburgh Schools of the Health Sciences

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Tiny implants for cells are functional in vivo

For the first time, an interdisciplinary team from the University of Basel has succeeded in integrating artificial organelles into the cells of live zebrafish embryos. This innovative approach using artificial organelles as cellular implants offers new potential in treating a range of diseases, as the authors report in an article published in Nature Communications.

In the cells of higher organisms, organelles such as the nucleus or mitochondria perform a range of complex functions necessary for life. In the networks of...

Im Focus: Locomotion control with photopigments

Researchers from Göttingen University discover additional function of opsins

Animal photoreceptors capture light with photopigments. Researchers from the University of Göttingen have now discovered that these photopigments fulfill an...

Im Focus: Surveying the Arctic: Tracking down carbon particles

Researchers embark on aerial campaign over Northeast Greenland

On 15 March, the AWI research aeroplane Polar 5 will depart for Greenland. Concentrating on the furthest northeast region of the island, an international team...

Im Focus: Unique Insights into the Antarctic Ice Shelf System

Data collected on ocean-ice interactions in the little-researched regions of the far south

The world’s second-largest ice shelf was the destination for a Polarstern expedition that ended in Punta Arenas, Chile on 14th March 2018. Oceanographers from...

Im Focus: ILA 2018: Laser alternative to hexavalent chromium coating

At the 2018 ILA Berlin Air Show from April 25–29, the Fraunhofer Institute for Laser Technology ILT is showcasing extreme high-speed Laser Material Deposition (EHLA): A video documents how for metal components that are highly loaded, EHLA has already proved itself as an alternative to hard chrome plating, which is now allowed only under special conditions.

When the EU restricted the use of hexavalent chromium compounds to special applications requiring authorization, the move prompted a rethink in the surface...

All Focus news of the innovation-report >>>



Industry & Economy
Event News

Virtual reality conference comes to Reutlingen

19.03.2018 | Event News

Ultrafast Wireless and Chip Design at the DATE Conference in Dresden

16.03.2018 | Event News

International Tinnitus Conference of the Tinnitus Research Initiative in Regensburg

13.03.2018 | Event News

Latest News

A new kind of quantum bits in two dimensions

19.03.2018 | Physics and Astronomy

Scientists have a new way to gauge the growth of nanowires

19.03.2018 | Materials Sciences

Virtual reality conference comes to Reutlingen

19.03.2018 | Event News

Science & Research
Overview of more VideoLinks >>>